Bharat Parenterals Limited (NSE:BPLPHARMA)

Market Cap	12.50B +51.7%
Revenue (ttm)	3.95B +10.6%
Net Income	12.44M
EPS	1.44
Shares Out	n/a
PE Ratio	1,246.75
Forward PE	n/a
Dividend	1.00 (0.06%)
Ex-Dividend Date	Sep 11, 2026

Volume	8,240
Open	1,891.50
Previous Close	1,916.90
Day's Range	1,761.50 - 1,916.90
52-Week Range	1,125.70 - 2,295.10
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Bharat Parenterals

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing general products in capsules, tablets, ointment and creams, i...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 404
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BPLPHARMA

Financial Performance

In fiscal year 2026, Bharat Parenterals's revenue was 3.45 billion, an increase of 1.48% compared to the previous year's 3.40 billion. Losses were -81.88 million, -35.15% less than in 2025.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 11, 2026

Data Sources Report a data error